Alesa Gel (2.5%+1%) is a Fixed-Dose Combination (FDC) Drug Brand being manufactured and marketed by Glenmark Pharmaceuticals Ltd.. This medicine is combination of more than one active ingredient or substance within a single pharmaceutical form type. The main active ingredients or salts in this drug are Clindamycin Phosphate, Benzoyl peroxide. This drug comes in the form of Sachet. The general packing available for this medicine consists of 1 Sachet and is priced at Rs 9.41 (arround $0.13174 US Dollar)
Generic (Salt) Combination :
(Clindamycin Phosphate+ Benzoyl peroxide)
Pharma Company :
Glenmark Pharmaceuticals Ltd.
Brand Label :
Alesa Gel (2.5%+1%)
Preparation Type :
Sachet
Single Dose :
1 Sachet
Composition (Fixed-Dose Combination) :
Clindamycin Phosphate-1% Benzoyl peroxide-2.5%
Pack Size/Qty/Vol :
1 Sachet
Price Unit :
Rs 9.41 INR (arround $0.13174 US Dollar)
Price Pack :
Rs 9.41 INR (arround $0.13174 US Dollar)
Drug details for Alesa Gel (2.5%+1%)
Usage: Why is this medication prescribed?
The main active ingredients or salts in Alesa Gel (2.5%+1%) are :
Clindamycin Phosphate-1% Benzoyl peroxide-2.5%
Clindamycin Phosphate Indication (Prescribed for or used as):
For more details on Clindamycin Phosphate, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Clindamycin Phosphate..
Benzoyl peroxide Indication (Prescribed for or used as): Acne vulgaris and acne rosacea.
For more details on Benzoyl peroxide, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Benzoyl peroxide..
Alesa Gel (2.5%+1%) Drug Brands Substitutes with similar Fixed-Dose Combination (FDC) :
There are 0 Fixed-Dose Combination (FDC) Drug Brands listed here as Substitutes for Alesa Gel (2.5%+1%), which have same Fixed-Dose Combination of active substances or ingredients (i.e. Clindamycin Phosphate-1% Benzoyl peroxide-2.5%). Please note that one can request a doctor or pharmacist to substitute a FDC Brand Version of the prescribed FDC drug brand, if any. Fixed-Dose Combination Drugs are being increasingly used due to the benefit of the combined effects of active ingredients given together. However, it is necessary to investigate the possible benefits in the clinical situation against possible disadvantages for each fixed combination drug and for each dose of the fixed combination drug. Potential advantages of fixed combination drugs may also include the counteracting by one ingredient of an adverse reaction produced by another one, and simplification of therapy, leading to improved compliance.